Abstract
Summary
The global Multi-Organ-on-a-Chip Models market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Multi-Organ-on-a-Chip Models is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Multi-Organ-on-a-Chip Models is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Multi-Organ-on-a-Chip Models is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Multi-Organ-on-a-Chip Models players cover Mimetas, TissUse, CN Bio Innovations, Hesperos, AxoSim, Elvesys and Beijing Abace Biotechnology, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Multi-Organ-on-a-Chip Model uses micro-processing technology to produce a bionic system that can simulate the main functions of multiple human organs on a microfluidic chip. Multi-Organ-on-a-Chip can construct multiple organs in different functional areas at the same time and connect them through chip pipelines.
LPI (LP Information)' newest research report, the “Multi-Organ-on-a-Chip Models Industry Forecast” looks at past sales and reviews total world Multi-Organ-on-a-Chip Models sales in 2022, providing a comprehensive analysis by region and market sector of projected Multi-Organ-on-a-Chip Models sales for 2023 through 2029. With Multi-Organ-on-a-Chip Models sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Multi-Organ-on-a-Chip Models industry.
This Insight Report provides a comprehensive analysis of the global Multi-Organ-on-a-Chip Models landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Multi-Organ-on-a-Chip Models portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Multi-Organ-on-a-Chip Models market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Multi-Organ-on-a-Chip Models and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Multi-Organ-on-a-Chip Models.
This report presents a comprehensive overview, market shares, and growth opportunities of Multi-Organ-on-a-Chip Models market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Gut/Liver-on-a-chip Model
Lung/Liver-on-a-chip Model
Nerve/Muscle-on-a-chip Model
Heart/Liver-on-a-chip Model
Others
Segmentation by application
Pharmaceutical
Research Institute
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Mimetas
TissUse
CN Bio Innovations
Hesperos
AxoSim
Elvesys
Beijing Abace Biotechnology
United States market for Multi-Organ-on-a-Chip Models is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Multi-Organ-on-a-Chip Models is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Multi-Organ-on-a-Chip Models is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Multi-Organ-on-a-Chip Models players cover Mimetas, TissUse, CN Bio Innovations, Hesperos, AxoSim, Elvesys and Beijing Abace Biotechnology, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Multi-Organ-on-a-Chip Model uses micro-processing technology to produce a bionic system that can simulate the main functions of multiple human organs on a microfluidic chip. Multi-Organ-on-a-Chip can construct multiple organs in different functional areas at the same time and connect them through chip pipelines.
LPI (LP Information)' newest research report, the “Multi-Organ-on-a-Chip Models Industry Forecast” looks at past sales and reviews total world Multi-Organ-on-a-Chip Models sales in 2022, providing a comprehensive analysis by region and market sector of projected Multi-Organ-on-a-Chip Models sales for 2023 through 2029. With Multi-Organ-on-a-Chip Models sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Multi-Organ-on-a-Chip Models industry.
This Insight Report provides a comprehensive analysis of the global Multi-Organ-on-a-Chip Models landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Multi-Organ-on-a-Chip Models portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Multi-Organ-on-a-Chip Models market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Multi-Organ-on-a-Chip Models and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Multi-Organ-on-a-Chip Models.
This report presents a comprehensive overview, market shares, and growth opportunities of Multi-Organ-on-a-Chip Models market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Gut/Liver-on-a-chip Model
Lung/Liver-on-a-chip Model
Nerve/Muscle-on-a-chip Model
Heart/Liver-on-a-chip Model
Others
Segmentation by application
Pharmaceutical
Research Institute
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Mimetas
TissUse
CN Bio Innovations
Hesperos
AxoSim
Elvesys
Beijing Abace Biotechnology
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Multi-Organ-on-a-Chip Models Market Size 2018-2029
2.1.2 Multi-Organ-on-a-Chip Models Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Multi-Organ-on-a-Chip Models Segment by Type
2.2.1 Gut/Liver-on-a-chip Model
2.2.2 Lung/Liver-on-a-chip Model
2.2.3 Nerve/Muscle-on-a-chip Model
2.2.4 Heart/Liver-on-a-chip Model
2.2.5 Others
2.3 Multi-Organ-on-a-Chip Models Market Size by Type
2.3.1 Multi-Organ-on-a-Chip Models Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Multi-Organ-on-a-Chip Models Market Size Market Share by Type (2018-2023)
2.4 Multi-Organ-on-a-Chip Models Segment by Application
2.4.1 Pharmaceutical
2.4.2 Research Institute
2.4.3 Others
2.5 Multi-Organ-on-a-Chip Models Market Size by Application
2.5.1 Multi-Organ-on-a-Chip Models Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Multi-Organ-on-a-Chip Models Market Size Market Share by Application (2018-2023)
3 Multi-Organ-on-a-Chip Models Market Size by Player
3.1 Multi-Organ-on-a-Chip Models Market Size Market Share by Players
3.1.1 Global Multi-Organ-on-a-Chip Models Revenue by Players (2018-2023)
3.1.2 Global Multi-Organ-on-a-Chip Models Revenue Market Share by Players (2018-2023)
3.2 Global Multi-Organ-on-a-Chip Models Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Multi-Organ-on-a-Chip Models by Regions
4.1 Multi-Organ-on-a-Chip Models Market Size by Regions (2018-2023)
4.2 Americas Multi-Organ-on-a-Chip Models Market Size Growth (2018-2023)
4.3 APAC Multi-Organ-on-a-Chip Models Market Size Growth (2018-2023)
4.4 Europe Multi-Organ-on-a-Chip Models Market Size Growth (2018-2023)
4.5 Middle East & Africa Multi-Organ-on-a-Chip Models Market Size Growth (2018-2023)
5 Americas
5.1 Americas Multi-Organ-on-a-Chip Models Market Size by Country (2018-2023)
5.2 Americas Multi-Organ-on-a-Chip Models Market Size by Type (2018-2023)
5.3 Americas Multi-Organ-on-a-Chip Models Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Multi-Organ-on-a-Chip Models Market Size by Region (2018-2023)
6.2 APAC Multi-Organ-on-a-Chip Models Market Size by Type (2018-2023)
6.3 APAC Multi-Organ-on-a-Chip Models Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Multi-Organ-on-a-Chip Models by Country (2018-2023)
7.2 Europe Multi-Organ-on-a-Chip Models Market Size by Type (2018-2023)
7.3 Europe Multi-Organ-on-a-Chip Models Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Multi-Organ-on-a-Chip Models by Region (2018-2023)
8.2 Middle East & Africa Multi-Organ-on-a-Chip Models Market Size by Type (2018-2023)
8.3 Middle East & Africa Multi-Organ-on-a-Chip Models Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Multi-Organ-on-a-Chip Models Market Forecast
10.1 Global Multi-Organ-on-a-Chip Models Forecast by Regions (2024-2029)
10.1.1 Global Multi-Organ-on-a-Chip Models Forecast by Regions (2024-2029)
10.1.2 Americas Multi-Organ-on-a-Chip Models Forecast
10.1.3 APAC Multi-Organ-on-a-Chip Models Forecast
10.1.4 Europe Multi-Organ-on-a-Chip Models Forecast
10.1.5 Middle East & Africa Multi-Organ-on-a-Chip Models Forecast
10.2 Americas Multi-Organ-on-a-Chip Models Forecast by Country (2024-2029)
10.2.1 United States Multi-Organ-on-a-Chip Models Market Forecast
10.2.2 Canada Multi-Organ-on-a-Chip Models Market Forecast
10.2.3 Mexico Multi-Organ-on-a-Chip Models Market Forecast
10.2.4 Brazil Multi-Organ-on-a-Chip Models Market Forecast
10.3 APAC Multi-Organ-on-a-Chip Models Forecast by Region (2024-2029)
10.3.1 China Multi-Organ-on-a-Chip Models Market Forecast
10.3.2 Japan Multi-Organ-on-a-Chip Models Market Forecast
10.3.3 Korea Multi-Organ-on-a-Chip Models Market Forecast
10.3.4 Southeast Asia Multi-Organ-on-a-Chip Models Market Forecast
10.3.5 India Multi-Organ-on-a-Chip Models Market Forecast
10.3.6 Australia Multi-Organ-on-a-Chip Models Market Forecast
10.4 Europe Multi-Organ-on-a-Chip Models Forecast by Country (2024-2029)
10.4.1 Germany Multi-Organ-on-a-Chip Models Market Forecast
10.4.2 France Multi-Organ-on-a-Chip Models Market Forecast
10.4.3 UK Multi-Organ-on-a-Chip Models Market Forecast
10.4.4 Italy Multi-Organ-on-a-Chip Models Market Forecast
10.4.5 Russia Multi-Organ-on-a-Chip Models Market Forecast
10.5 Middle East & Africa Multi-Organ-on-a-Chip Models Forecast by Region (2024-2029)
10.5.1 Egypt Multi-Organ-on-a-Chip Models Market Forecast
10.5.2 South Africa Multi-Organ-on-a-Chip Models Market Forecast
10.5.3 Israel Multi-Organ-on-a-Chip Models Market Forecast
10.5.4 Turkey Multi-Organ-on-a-Chip Models Market Forecast
10.5.5 GCC Countries Multi-Organ-on-a-Chip Models Market Forecast
10.6 Global Multi-Organ-on-a-Chip Models Forecast by Type (2024-2029)
10.7 Global Multi-Organ-on-a-Chip Models Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 Mimetas
11.1.1 Mimetas Company Information
11.1.2 Mimetas Multi-Organ-on-a-Chip Models Product Offered
11.1.3 Mimetas Multi-Organ-on-a-Chip Models Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Mimetas Main Business Overview
11.1.5 Mimetas Latest Developments
11.2 TissUse
11.2.1 TissUse Company Information
11.2.2 TissUse Multi-Organ-on-a-Chip Models Product Offered
11.2.3 TissUse Multi-Organ-on-a-Chip Models Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 TissUse Main Business Overview
11.2.5 TissUse Latest Developments
11.3 CN Bio Innovations
11.3.1 CN Bio Innovations Company Information
11.3.2 CN Bio Innovations Multi-Organ-on-a-Chip Models Product Offered
11.3.3 CN Bio Innovations Multi-Organ-on-a-Chip Models Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 CN Bio Innovations Main Business Overview
11.3.5 CN Bio Innovations Latest Developments
11.4 Hesperos
11.4.1 Hesperos Company Information
11.4.2 Hesperos Multi-Organ-on-a-Chip Models Product Offered
11.4.3 Hesperos Multi-Organ-on-a-Chip Models Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Hesperos Main Business Overview
11.4.5 Hesperos Latest Developments
11.5 AxoSim
11.5.1 AxoSim Company Information
11.5.2 AxoSim Multi-Organ-on-a-Chip Models Product Offered
11.5.3 AxoSim Multi-Organ-on-a-Chip Models Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 AxoSim Main Business Overview
11.5.5 AxoSim Latest Developments
11.6 Elvesys
11.6.1 Elvesys Company Information
11.6.2 Elvesys Multi-Organ-on-a-Chip Models Product Offered
11.6.3 Elvesys Multi-Organ-on-a-Chip Models Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Elvesys Main Business Overview
11.6.5 Elvesys Latest Developments
11.7 Beijing Abace Biotechnology
11.7.1 Beijing Abace Biotechnology Company Information
11.7.2 Beijing Abace Biotechnology Multi-Organ-on-a-Chip Models Product Offered
11.7.3 Beijing Abace Biotechnology Multi-Organ-on-a-Chip Models Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Beijing Abace Biotechnology Main Business Overview
11.7.5 Beijing Abace Biotechnology Latest Developments
12 Research Findings and Conclusion